CRISPR Therapeutics
CRSP
#3176
Rank
$3.86 B
Marketcap
$45.36
Share price
-0.02%
Change (1 day)
5.34%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -$5.30

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.30. In 2022 the company made an earnings per share (EPS) of -$8.37 a decrease over its 2021 EPS that were of $4.99.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.30-36.68%
2022-$8.37-267.74%
2021$4.99-194.33%
2020-$5.29-576.58%
2019$1.11-132.36%
2018-$3.43100.58%
2017-$1.71159.42%
2016-$0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.18-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA